Anneke Ten Brinke

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response

Margaret J Leckie, Anneke Ten Brinke, Jamey Khan et al. · The Lancet · 2000 · 1.8K citations

Life Sciences, Immunology, Internal Medicine +13

Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial

Geoffrey Chupp, Eric Bradford, Frank C. Albers et al. · The Lancet Respiratory Medicine · 2017 · 590 citations

Medicine, Pharmacology, Pharmacotherapy +14

Risk factors of frequent exacerbations in difficult-to-treat asthma

Anneke Ten Brinke, PJ Sterk, A. A. M. Masclee et al. · European Respiratory Journal · 2005 · 492 citations · Full text

Pharmacy, Health Sciences, Pharmacotherapy +14

Factors Associated with Persistent Airflow Limitation in Severe Asthma

Anneke Ten Brinke, Aeilko H. Zwinderman, Peter Sterk et al. · American Journal of Respiratory and Critical Care Medicine · 2001 · 360 citations

Medicine, Clinical Sciences, Internal Medicine +17

Chronic sinusitis in severe asthma is related to sputum eosinophilia

Anneke Ten Brinke, Diana C. Grootendorst, Judith Schmidt et al. · Journal of Allergy and Clinical Immunology · 2002 · 313 citations · Full text

Medicine, Immunology, Otolaryngology +12